Short‐term clinical outcomes and predicted cost savings of dd‐cfDNA‐led surveillance after pediatric heart transplantation
Short‐term clinical outcomes and predicted cost savings of dd‐cfDNA‐led surveillance after pediatric heart transplantation is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Short‐term clinical outcomes and predicted cost savings of dd‐cfDNA‐led surveillance after pediatric heart transplantation have?
Short‐term clinical outcomes and predicted cost savings of dd‐cfDNA‐led surveillance after pediatric heart transplantation has 17 citations in the OpenAlex counts ScholarIQ stores.
When was Short‐term clinical outcomes and predicted cost savings of dd‐cfDNA‐led surveillance after pediatric heart transplantation published?
Short‐term clinical outcomes and predicted cost savings of dd‐cfDNA‐led surveillance after pediatric heart transplantation has 2023 year in the ScholarIQ index.
What is the open-access status of Short‐term clinical outcomes and predicted cost savings of dd‐cfDNA‐led surveillance after pediatric heart transplantation?
Short‐term clinical outcomes and predicted cost savings of dd‐cfDNA‐led surveillance after pediatric heart transplantation has hybrid oa status in the ScholarIQ index.
What is the DOI of Short‐term clinical outcomes and predicted cost savings of dd‐cfDNA‐led surveillance after pediatric heart transplantation?
The DOI for Short‐term clinical outcomes and predicted cost savings of dd‐cfDNA‐led surveillance after pediatric heart transplantation is on the source record.
What is the PMID of Short‐term clinical outcomes and predicted cost savings of dd‐cfDNA‐led surveillance after pediatric heart transplantation?
The PMID for Short‐term clinical outcomes and predicted cost savings of dd‐cfDNA‐led surveillance after pediatric heart transplantation is on the source record.
What is the OpenAlex record for Short‐term clinical outcomes and predicted cost savings of dd‐cfDNA‐led surveillance after pediatric heart transplantation?
The OpenAlex for Short‐term clinical outcomes and predicted cost savings of dd‐cfDNA‐led surveillance after pediatric heart transplantation is on the source record.